
The Endocannabinoidome
The World of Endocannabinoids and Related Mediators
- 1st Edition - September 18, 2014
- Imprint: Academic Press
- Editors: Vincenzo Di Marzo, Jenny Wang
- Language: English
- Paperback ISBN:9 7 8 - 0 - 1 2 - 4 2 0 1 2 6 - 2
- eBook ISBN:9 7 8 - 0 - 1 2 - 8 0 0 4 2 9 - 6
The Endocannabinoidome: The World of Endocannabinoids and Related Mediators is dedicated to the latest research and studies on endocannabinoids and cannabinoid receptors to ill… Read more

Purchase options

Institutional subscription on ScienceDirect
Request a sales quoteThe Endocannabinoidome: The World of Endocannabinoids and Related Mediators is dedicated to the latest research and studies on endocannabinoids and cannabinoid receptors to illustrate their important role in the discovery of new, endocannabinoid-related, lipid mediators. Written by leading experts across different disciplines, this book focuses on the biochemical and anlayticial aspects of novel lipid signals, their pharmacological activities and their potential utilization for the development of new and effective therapeutic strategies. The first book of its kind, The Endocannabinoidome is a meaningful reference for all those involved in experimental efforts to further the development of this field.
- Explores the novel and exciting aspects of several endocannabinoid-like molecules for which researchers are still seeking a function
- Discusses the novel metabolic pathways for endocannabinoids in order to explain the failure of some clinical trials with inhibitors of more conventional metabolic pathways
- Incorporates pharmacology, biochemistry and potential clinical applications to provide researchers with a complete look at endocannabinoids
- Dedications
- Contributors
- Preface
- Acknowledgments
- Chapter 1: Non-endocannabinoid N-Acylethanolamines and Monoacylglycerols: Old Molecules New Targets
- Abstract
- 1.1. Introduction
- 1.2. Formation and degradation of N-acylethanolamines
- 1.3. Biological roles and drug targets of non-endocannabinoid N-acylethanolamines
- 1.4. Formation and degradation of non-endocannabinoid 2-monoacylglycerols
- 1.5. Biological roles and drug targets of non-endocannabinoid 2-monoacylglycerols
- 1.6. Conclusion
- Acknowledgment
- Chapter 2: Omega-3 Polyunsaturated N-Acylethanolamines: A Link Between Diet and Cellular Biology
- Abstract
- 2.1. Introduction
- 2.2. Modulation of the endocannabinoidome by dietary fatty acids – biochemical aspects
- 2.3. Effects of diet – animal studies
- 2.4. Effects of diet – human data
- 2.5. In vitro formation of n-3 fatty acid derived amides
- 2.6. Biological effects of n-3 fatty acid derived NAEs and other amides
- 2.7. Conclusions and future perspectives
- Chapter 3: N-Acyl Amides: Ubiquitous Endogenous Cannabimimetic Lipids That Are in the Right Place at the Right Time
- Abstract
- 3.1. N-acyl amides: all in the family
- 3.2. GPR18
- 3.3. N-acyl amides/endogenous cannabinoids that activate TRP receptors
- 3.4. N-acyl amide/eCBs with not yet identified phytocannabinoid ligands
- 3.5. Nowhere to go but up
- Chapter 4: Oxidative Metabolites of Endocannabinoids Formed by Cyclooxygenase-2
- Abstract
- 4.1. COX-2 metabolism of endocannabinoids
- 4.2. Analysis of ECs and their COX-2 metabolites
- 4.3. Tools to study PG-G and PG-EA functions
- 4.4. Biological effects of PG-Gs and PG-EAs
- 4.5. Perspective
- Chapter 5: N-Acyldopamines and N-Acylserotonins: From Synthetic Pharmacological Tools to Endogenous Multitarget Mediators
- Abstract
- 5.1. Introduction
- 5.2. N-acyldopamines
- 5.3. N-acylserotonins
- 5.4. Conclusions
- Chapter 6: The Pharmacology of Prostaglandin F2α Ethanolamide and Bimatoprost Reveals a Unique Feedback Mechanism on Endocannabinoid Actions
- Abstract
- 6.1. Introduction
- 6.2. Pharmacology
- 6.3. Endogenous prostamide PGF2α
- 6.4. Prostamide receptor detection
- 6.5. Biological function and therapeutics
- Acknowledgment
- Chapter 7: Prostamide F2α Biosynthesizing Enzymes
- Abstract
- 7.1. Introduction
- 7.2. PGF synthases belonging to the aldo-keto reductase superfamily: molecular structure and properties
- 7.3. Prostamide/PGF synthase: properties
- 7.4. AKR1C3 and related PGF synthases and prostamide/PGF synthase: substrates and inhibitors
- 7.5. Comparative distribution of AKR1C3 and related AKR enzymes with prostamide/PGF synthase
- 7.6. Prostamide/PGF synthase AKR1C3 and related PGF synthases and their relation to biological function and therapeutics
- Chapter 8: Metabolic Enzymes for Endocannabinoids and Endocannabinoid-Like Mediators
- Abstract
- 8.1. Introduction
- 8.2. Enzymes for the biosynthesis of N-acylethanolamines
- 8.3. Enzymes for the degradation of N-acylethanolamines
- 8.4. Enzymes for the biosynthesis of 2-AG
- 8.5. Enzymes for the degradation of 2-AG
- 8.6. Perspectives
- Chapter 9: Endocannabinoidomics: “Omics” Approaches Applied to Endocannabinoids and Endocannabinoid-Like Mediators
- Abstract
- 9.1. Introduction
- 9.2. Biochemistry and pharmacology of endocannabinoids and endocannabinoid-related compounds
- 9.3. Lipidomics in “endocannabinoidomics”: mass-spectrometric approaches for endocannabinoid and endocannabinoid-like molecule quantification
- 9.4. New frontiers
- 9.5. Conclusions
- Chapter 10: Common Receptors for Endocannabinoid-Like Mediators and Plant Cannabinoids
- Abstract
- 10.1. Introduction
- 10.2. CB1 and CB2 receptors
- 10.3. Beyond CB1 and CB2 receptors: cannabinoid receptor-like GPCR
- 10.4. Ligand- and voltage-gated ion channels
- 10.5. Nuclear hormone receptors
- 10.6. Amplification of endocannabinoid tone
- 10.7. Concluding remarks
- Index
- Edition: 1
- Published: September 18, 2014
- Imprint: Academic Press
- No. of pages: 208
- Language: English
- Paperback ISBN: 9780124201262
- eBook ISBN: 9780128004296
VD
Vincenzo Di Marzo
JW